Study Findings from Kanagawa Cancer Center Provide New Insights into Liver Cancer (A randomized, double-blind, placebo-controlled, phase 3 study of tivantinib in Japanese patients with MET-high hepatocellular carcinoma)

Source :: Obesity, Fitness & Wellness Week. September 12, 2020, 2101
Publication Year :: 2020
Abstract: 2020 SEP 12 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Oncology - Liver Cancer is the subject of a [...]

Subjects :: Physical fitness -- Research -- Reports
Hepatocellular carcinoma -- Research -- Care and treatment
Cancer research -- Reports
Sorafenib -- Research
Health

Tools